NDC 52959-910 - Hypertenipine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 52959-910
- Package NDCs from labels
- 52959-910-30
- Manufacturer
- Physician Therapeutics LLC | InvaGen Pharmaceuticals, Inc | H.J. Harkins Company, Inc. | Targeted Medical Pharma, Inc.
- Effective date
- 2011-08-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hypertenipine-2.5 | Physician Therapeutics LLC | InvaGen Pharmaceuticals, Inc | H.J. Harkins Company, Inc. | Targeted Medical Pharma, Inc. | 2011-08-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52959-910-30 | Hypertenipine | 30 in 1 BOTTLE | TABLET | 30 | 2.5 mg | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ledum Combination 9257 | LEDUM COMBINATION | Professional Complementary Health Formulas | 38b89b32-4915-487d-8b2d-250123487b15 | 2026-01-08 | Warnings | L11K75P92J |
| RET Lung 7003 | RET LUNG | Professional Complementary Health Formulas | 2ed03832-f226-4b3c-9ee6-5352f8d79fdb | 2026-01-08 | Warnings | L11K75P92J |
| Myosotis Combination 9234 | MYOSOTIS COMBINATION | Professional Complementary Health Formulas | 8cc292dc-b959-4d81-8277-03044992fccb | 2026-01-08 | Warnings | L11K75P92J |
| L-Arginine High 7402 | L-ARGININE HIGH | Professional Complementary Health Formulas | 5274a1f6-dfa2-452a-9077-0f66eee4e22b | 2026-01-08 | Warnings | 94ZLA3W45F |
| Anti-Scar Drops 2084 | ANTI-SCAR DROPS | Professional Complementary Health Formulas | ad0e9159-ed68-48aa-a7d1-7ff5c32ec304 | 2026-01-08 | Warnings | L11K75P92J |
| Fifth Chakra (Throat) 7305 | FIFTH CHAKRA (THROAT) | Professional Complementary Health Formulas | b731f708-10a8-451f-8550-1e7302102b96 | 2026-01-08 | Warnings | L11K75P92J |
| Dementia Drops 2117 | DEMENTIA DROPS | Professional Complementary Health Formulas | 83aec02b-bc62-49a2-ba35-4ac94f9bfc6e | 2026-01-08 | Warnings | L11K75P92J |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | e01efe66-2f31-4261-92ca-0b41f27104da | 2026-01-07 | Warnings, Adverse reactions | 308136 864V2Q084H |
| Olmesartan medoxomil, amlodipine and hydrochlorothiazide | OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE | Camber Pharmaceuticals, Inc. | 45e975ff-07b1-411a-96ee-a011d1619b1e | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE and OLMESARTAN medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | Macleods Pharmaceuticals Limited | c86a3c45-c906-46c9-9f7b-6c3d89bbe48f | 2026-01-03 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Northwind Health Company, LLC | fa153720-b24c-60d0-e053-6294a90a97d5 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | Northwind Health Company, LLC | f2b56630-4e3a-6f9c-e053-2a95a90a4650 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Northwind Health Company, LLC | f2b8274b-d849-6793-e053-2a95a90aa0e8 | 2026-01-01 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Northwind Health Company, LLC | f32bb322-68d7-a4ca-e053-2995a90aa7b0 | 2026-01-01 | Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Northwind Health Company, LLC | 0c5784b9-5542-144f-e063-6394a90a7ebc | 2026-01-01 | Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Northwind Health Company, LLC | 03fe9ad2-3a1a-78db-e063-6294a90a2ed3 | 2026-01-01 | Warnings, Adverse reactions | 864V2Q084H |
| amlodipine and valsartan | AMLODIPINE AND VALSARTAN | Macleods Pharmaceuticals Limited | 5dfadaf0-c333-4b79-9a97-e42f77505c40 | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Northwind Health Company, LLC | 0de6a6d0-a114-e114-e063-6394a90a34dd | 2025-12-26 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Northwind Health Company, LLC | 106c08c2-90eb-6bc0-e063-6294a90a5a23 | 2025-12-26 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | 2b0e3752-c54e-4c50-9640-1a6fefa6dec5 | 2025-12-19 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.